Summary from the original article

Diabetes patients who stop taking GLP-1s may face double the risk of heart attack, stroke or early death compared with those who stay on the drugs, a large study has found.
AI key points, how left, center and right framed this story, tone by side and loaded language are part of News.gg Premium.
Upgrade this serverDiabetes patients who stop taking GLP-1s may face double the risk of heart attack, stroke or early death compared with those who stay on the drugs, a large study has found.
2 days ago · dailymail.com · You are reading this one